Recombinant Human GPR35 Protein，His

GPR35 is a G protein-coupled receptor that has garnered interest in recent years due to its involvement in various physiological and pathological processes, including immune response, inflammation, and metabolic regulation. Identified as a receptor for kynurenic acid and certain other ligands, GPR35 is believed to play a role in gastrointestinal disorders, cardiovascular diseases, and even cancer. The complexity of its signaling pathways, which may involve β-arrestin and Gq/11 proteins, highlights the need for a deeper understanding of its mechanisms. However, challenges in obtaining functional studies of GPR35 have arisen, primarily due to difficulties in expressing and purifying the receptor in recombinant systems. As a result, a focused effort on the production of recombinant GPR35 protein has emerged, which aims to facilitate detailed pharmacological analyses and structural studies. Such research is crucial for elucidating the receptor's biological functions and potential as a therapeutic target. Advances in protein expression techniques, coupled with the development of specific ligands and antibodies, are expected to accelerate discoveries related to GPR35, potentially leading to novel interventions for diseases linked to this receptor.